These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 32553527)

  • 1. Clinical features of tuberculosis and Bacillus Calmette-Guérin (BCG) -associated adverse effects in children: A 12-year study.
    Yang TL; Lee CM; Lee KL; Yen TY; Lu CY; Lee PI; Chen CM; Huang LM; Chang LY
    J Formos Med Assoc; 2021 Jan; 120(1 Pt 2):443-451. PubMed ID: 32553527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of pulmonary and extrapulmonary tuberculosis in immunocompetent adults: a retrospective case series analysis.
    Guler SA; Bozkus F; Inci MF; Kokoglu OF; Ucmak H; Ozden S; Yuksel M
    Med Princ Pract; 2015; 24(1):75-9. PubMed ID: 25341702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extrapulmonary tuberculosis: epidemiology and risk factors.
    García-Rodríguez JF; Álvarez-Díaz H; Lorenzo-García MV; Mariño-Callejo A; Fernández-Rial Á; Sesma-Sánchez P
    Enferm Infecc Microbiol Clin; 2011; 29(7):502-9. PubMed ID: 21570159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inoculation Age of Bacillus Calmette-Guérin Tokyo-172 Strain and Vaccine-related Adverse Reactions in Taiwan Birth Cohort of 2012-2017.
    Huang W; Chiu NC; Chi H; Huang FY; Huang CY
    Clin Infect Dis; 2021 Oct; 73(7):e1554-e1559. PubMed ID: 32827439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison TLR2 and TLR4 serum levels in children with pulmonary and extrapulmonary tuberculosis with and without a Bacillus Calmette-Guérin (BCG) scar.
    Shabariah R; Hatta M; Idris I; Santoso A; Patellongi I; Permatasari TAE; Farsida ; Islam AA; Natzir R; Wahyudin B; Warsinggih ; Emilda
    J Clin Tuberc Other Mycobact Dis; 2021 Dec; 25():100272. PubMed ID: 34504953
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Infant BCG vaccination and risk of pulmonary and extrapulmonary tuberculosis throughout the life course: a systematic review and individual participant data meta-analysis.
    Martinez L; Cords O; Liu Q; Acuna-Villaorduna C; Bonnet M; Fox GJ; Carvalho ACC; Chan PC; Croda J; Hill PC; Lopez-Varela E; Donkor S; Fielding K; Graham SM; Espinal MA; Kampmann B; Reingold A; Huerga H; Villalba JA; Grandjean L; Sotgiu G; Egere U; Singh S; Zhu L; Lienhardt C; Denholm JT; Seddon JA; Whalen CC; García-Basteiro AL; Triasih R; Chen C; Singh J; Huang LM; Sharma S; Hannoun D; Del Corral H; Mandalakas AM; Malone LL; Ling DL; Kritski A; Stein CM; Vashishtha R; Boulahbal F; Fang CT; Boom WH; Netto EM; Lemos AC; Hesseling AC; Kay A; Jones-López EC; Horsburgh CR; Lange C; Andrews JR
    Lancet Glob Health; 2022 Sep; 10(9):e1307-e1316. PubMed ID: 35961354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modelling the effect of discontinuing universal Bacillus Calmette-Guérin vaccination in an intermediate tuberculosis burden setting.
    Fu H; Lin HH; Hallett TB; Arinaminpathy N
    Vaccine; 2018 Sep; 36(39):5902-5909. PubMed ID: 30143270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parasternal mass revealing as a postvaccinal Bacillus Calmette-Guérin (BCG)-elicited sternal osteomyelitis.
    Ahn HY; Kim YD; Jeon SE; Park SS; Park SE; Lee IS; Choi KW
    Thorac Cardiovasc Surg; 2014 Apr; 62(3):258-60. PubMed ID: 23344749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High proportion of extrapulmonary tuberculosis in a low prevalence setting: a retrospective cohort study.
    Sama JN; Chida N; Polan RM; Nuzzo J; Page K; Shah M
    Public Health; 2016 Sep; 138():101-7. PubMed ID: 27137870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characteristics and incidence of vaccine adverse events after Bacille Calmette-Guérin vaccination: A national surveillance study in Japan from 2013 to 2017.
    Okuno H; Satoh H; Morino S; Arai S; Ochiai M; Fujita K; Naito S; Kato A; Ishii K; Oishi K; Suzuki M; Tanaka-Taya K
    Vaccine; 2022 Aug; 40(33):4922-4928. PubMed ID: 35690499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical characteristics of tuberculosis in children in the north of Taiwan.
    Lin YS; Huang YC; Chang LY; Lin TY; Wong KS
    J Microbiol Immunol Infect; 2005 Feb; 38(1):41-6. PubMed ID: 15692626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trends in incidence of extrapulmonary tuberculosis in children in the Czech Republic in the past 35 years.
    Doležalová K; Kika V; Göpfertová D; Wallenfels J
    Cent Eur J Public Health; 2022 Dec; 30(4):207-212. PubMed ID: 36718921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical Manifestations, Management, and Outcomes of Osteitis/Osteomyelitis Caused by Mycobacterium bovis Bacillus Calmette-Guérin in Children: Comparison by Site(s) of Affected Bones.
    Huang CY; Chiu NC; Chi H; Huang FY; Chang PH
    J Pediatr; 2019 Apr; 207():97-102. PubMed ID: 30577978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cold abscess of the chest wall as an unusual complication of BCG vaccination.
    Aribas OK; Kanat F; Gormus N; Turk E
    Eur J Cardiothorac Surg; 2002 Feb; 21(2):352-4. PubMed ID: 11825754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adverse reactions to the Bacillus Calmette-Guérin (BCG) vaccine in new-born infants-an evaluation of the Danish strain 1331 SSI in a randomized clinical trial.
    Nissen TN; Birk NM; Kjærgaard J; Thøstesen LM; Pihl GT; Hoffmann T; Jeppesen DL; Kofoed PE; Greisen G; Benn CS; Aaby P; Pryds O; Stensballe LG
    Vaccine; 2016 May; 34(22):2477-82. PubMed ID: 27060379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of BCG vaccination of the newborn: evaluation by a follow-up study of contacts in Bangui.
    Lanckriet C; Lévy-Bruhl D; Bingono E; Siopathis RM; Guérin N
    Int J Epidemiol; 1995 Oct; 24(5):1042-9. PubMed ID: 8557438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The rate of adverse events following BCG vaccination in Poland.
    Krysztopa-Grzybowska K; Paradowska-Stankiewicz I; Lutyńska A
    Przegl Epidemiol; 2012; 66(3):465-9. PubMed ID: 23230718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Osteomyelitis Caused by Bacillus Calmette-Guérin Vaccination in a Healthy Toddler.
    Avcu G; Sahbudak Bal Z; Cavusoglu C; Vardar F
    J Trop Pediatr; 2020 Feb; 66(1):103-105. PubMed ID: 31180499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Costal BCG osteomyelitis developing 1 year after BCG vaccination.
    Oyachi N; Obana K; Suzuki T; Kimura S; Chino K; Oyama T; Takano K
    Pediatr Int; 2013 Oct; 55(5):641-3. PubMed ID: 24134752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and Immunogenicity of Early Bacillus Calmette-Guérin Vaccination in Infants Who Are Preterm and/or Have Low Birth Weights: A Systematic Review and Meta-analysis.
    Badurdeen S; Marshall A; Daish H; Hatherill M; Berkley JA
    JAMA Pediatr; 2019 Jan; 173(1):75-85. PubMed ID: 30476973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.